Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piragliatin in Type 2 Diabetes Mellitus
NCT00316758Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of piragliatin in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Feb 2006; status: completed.
02
Drugs
piragliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00316758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316758.